title: Key strategic factors for stakeholders in the current global biosimilar market.
abstract: What are the strategies of success in the global biosimilar market? In general, originators have short-term options available, such as patent litigation, but should focus on sustainable long-term strategies such as development of biobetters or incorporating biosimilars as complements to existing products. For new entrants to the market, the learning curve will be steep and only biosimilars developed to compete with the best-selling biologics will be successful over the next decade. The attitudes of physicians, patients and payers will be crucial to the reception future biosimilars will receive and it will be essential that other players contribute to this debate.
authors.affiliation: Medical Sciences Division, University of Oxford, OX1 4JD, UK. Electronic address: daniel.a.j.casey@outlook.com.
authors.forename: Daniel
authors.initials: D
authors.lastname: Casey
mesh_terms: D059451:Biosimilar Pharmaceuticals; D004345:Drug Industry; D016568:Drugs, Generic; D038622:Internationality
chemical_list: D059451:Biosimilar Pharmaceuticals; D016568:Drugs, Generic